For laboratory research only · Not for human or veterinary use

Skip to content
An 80 mg KLOW vial: clear glass with a silver crimped cap, labelled KLOW 80MG, peptide research, research use only.
Lot NVE-2440-AVerified

KLOW

GHK-Cu + KPV + TB-500 + BPC-157 blend

Each vial contains 50 mg of GHK-Cu, 10 mg of KPV, 10 mg of TB-500 and 10 mg of BPC-157.

KLOW is a four-component mixture supplied in one vial: GHK-Cu, KPV, TB-500 and BPC-157. No published work examines the mixture, and a finding for one component is not a finding for the four. What each component’s own literature covers is set out under How it works below.

  • Four-peptide blend: GHK-Cu, KPV, TB-500, BPC-157
  • Lyophilized powder, requires reconstitution
Vial size

Price

$150.00 CAD

In stock

Produced & shipped in Canada

Specification

Purity
≥ 98.5% by RP-HPLC
Form
Lyophilized powder
Third-party assay
Purity, fill and endotoxin
Origin
Canada
Storage
Refrigerated, 2-8 °C
Lot
NVE-2440-A
Contains
GHK-Cu 50 mg · KPV 10 mg · TB-500 10 mg · BPC-157 10 mg

Standard formulation. Where a certificate exists for the lot, it records the fill actually measured.

How it works

Four peptides in one vial. Each has a literature of its own and none of it examines the mixture, so what follows is what has been studied about each separately.

  • GHK-Cu

    Copper-binding tripeptide

    Cell culture and animal work on gene expression and on extracellular matrix proteins, collagen among them. The human studies are small and concern topical preparations, which is a different literature from lyophilised material in a vial.

  • KPV

    C-terminal fragment of alpha-MSH

    The three residues that carry that hormone’s anti-inflammatory signalling in cell work. Rodent models of colitis and of skin inflammation, and studies of the NF-κB pathway.

  • TB-500

    Fragment of thymosin beta-4

    Animal work on actin sequestration and cell migration in wound and cardiac injury models. The full protein is a different molecule and its human data is not this fragment’s.

  • BPC-157

    Fifteen-amino-acid sequence

    Rodent tendon, ligament, muscle and gastrointestinal injury models, concentrated in a small number of research groups.

Where the evidence stands

Every component is preclinical apart from small topical studies of GHK-Cu. No controlled human trials have been published for the mixture, and combining studied compounds does not produce a studied compound. Neither the mixture nor any component of it is approved as a medicine.

Working-solution calculator

Laboratory results

Opened as the laboratory issued them, unedited. Every certificate we publish

Research use only

Supplied as a laboratory research chemical. Not a drug, food or cosmetic, and not for human or veterinary use. No application guidance is provided or implied.